Rechercher dans ce blog

Wednesday, March 31, 2021

U.S. begins testing Moderna's Covid vaccine booster shots for variant from South Africa - CNBC


A nurse draws a Moderna coronavirus disease (COVID-19) vaccine, at East Valley Community Health Center in La Puente, California, March 5, 2021.

Lucy Nicholson | Reuters

The National Institutes of Health has started testing a new coronavirus vaccine from Moderna designed to protect against a problematic variant first found in South Africa, the agency said Wednesday.

The phase one trial, led and funded by the NIH's National Institute of Allergy and Infectious Diseases, will test how safe and effective the new shot is against the variant — known as B.1.351 — in roughly 210 healthy adults, according to the agency.

CNBC Health & Science

The trial, which has already administered some of its first shots, will include approximately 60 adults who participated in Moderna's original Covid-19 vaccine trials last year, as well as approximately 150 people who haven't received any Covid-19 vaccine yet, according to a statement.

The returning participants who were given two shots of the original vaccine 28 days apart at varying doses early last year will split up.

Some of them will be given a single booster shot with the new vaccine at a higher dose while some will receive the new vaccine at a lower dose, the statement said. The remaining participants will be offered a booster shot with the original vaccine "as part of a separate clinical trial protocol."

Researchers will take blood samples from participants throughout the trial that can be tested against other circulating strains of the virus to determine whether the vaccine produces an immune response.

The trial will recruit volunteers in the Atlanta, Cincinnati, Seattle, and Nashville, Tennessee, areas and should be fully enrolled by the end of April, the agency said.

The B.1.351 variant first discovered in South Africa late last year has given scientists more cause for concern compared with other variants. The variant appears to spread easier than the "wild type" original strains, and research indicates it can possibly evade some of the protections generated by therapeutics and vaccines.

So far, there have been 312 Covid-19 cases with the B.1.351 variant identified in the U.S., according to the latest data from the Centers for Disease Control and Prevention.

"Preliminary data show that the COVID-19 vaccines currently available in the United States should provide an adequate degree of protection against SARS-CoV-2 variants," NIAID Director and White House chief medical advisor Dr. Anthony Fauci said in a statement.

"However, out of an abundance of caution, NIAID has continued its partnership with Moderna to evaluate this variant vaccine candidate should there be a need for an updated vaccine," Fauci said.

The U.S. Food and Drug Administration has previously said it will expedite the authorization process for the updated vaccines that target the troublesome variants, eliminating the need for lengthy clinical trials.

However, an independent safety monitoring committee will continue to oversee the trials to ensure the shots are safe, the NIH statement said.

The Link Lonk


April 01, 2021 at 03:01AM
https://ift.tt/2PfeBvl

U.S. begins testing Moderna's Covid vaccine booster shots for variant from South Africa - CNBC

https://ift.tt/2DVP6sH

Wilson Electronics Announces Most Powerful RV Cell Booster on the Market - the weBoost Destination RV - Business Wire


SALT LAKE CITY--()--Wilson Electronics, the industry leader in cellular signal booster technology, today announced the launch of the weBoost Destination RV, a powerful, consumer-friendly cell signal booster designed to provide solid cellular connectivity in stationary touring and destination RVs, toy haulers and trailers. Compatible with all mobile devices and wireless carriers in North America, the booster allows users to enjoy optimal call quality, fewer dead zones, uninterrupted texts and faster data streaming.

“As the pandemic continues, more and more people are turning to RVs as a safe, responsible way to travel and get beyond their homes’ four walls,” said Wilson Electronics’ CEO Bruce Lancaster. “ The Destination RV is the obvious choice for anyone that’s looking to ensure strong cell signal on any cellular-connected device, no matter where ‘home’ is that month.”

Over the past year, the RV industry has seen huge growth. In an industry previously dominated by retirees, RVs are now being increasingly utilized by young families and couples as remote working and learning opportunities have increased. In fact, 82% of first-time campers in 2020 had children in their household, and interest in full-time RVing is highest among millennials, according to Kampgrounds of America’s annual North American Camping Report. These younger campers need consistent access to technology in order to meet remote work and learning responsibilities, but the Wi-Fi offered by campgrounds is often too weak or spotty to be reliable for these needs.

The weBoost Destination RV provides the perfect solution. Whether to stay safe in emergencies, connect with friends and family, or continue to work and learn remotely from anywhere, weBoost’s new booster is a simple, reliable way to improve cellular connectivity in RVs, toy haulers and trailers.

The Destination RV combines the mobility of an RV cell signal booster kit with the power of a residential cell signal booster. Utilizing the weBoost Home MultiRoom’s powerful amplifier and external antenna to provide a max gain of 65 dB, the Destination RV can reach far away cell towers with ease. The weBoost Destination RV is also optimized for the continued rollout of 5G and prepared to boost cell signal for all major carriers for the next decade and beyond.

Out of the box, the Destination RV features everything needed for easy, do-it-yourself installation, including:

  • Cell signal booster
  • Inside antenna
  • Outside directional antenna
  • 25 ft. telescoping pole
  • Outside antenna mounting hardware
  • Power supply and cables

How it works: The powerful exterior antenna reaches out to cell phone towers to receive a signal. The Destination RV booster receives this outside signal and amplifies it using a series of sophisticated low noise amplifiers and filters. This amplified signal is broadcast through the inside antenna and back to the tower, providing stronger, more reliable calls, texting and data in the RV.

Installation takes about 30 minutes for most consumers, and each subsequent takedown and setup when changing the RV’s stationary location takes about 10 minutes.

Certified by the FCC and Industry Canada and pre-approved by all carriers, the weBoost Destination RV is now available for purchase online at weBoost.com, weBoost.ca, or through authorized resellers for $649.99 USD or $899.99 CAD. The only cellular booster company that designs, assembles and tests its products solely in the U.S., all weBoost cellular signal boosters feature a two-year manufacturer’s warranty and a 30-day money-back guarantee.

For more information, please visit www.weboost.com or follow weBoost using @weBoost on Facebook, Twitter and Instagram.

About weBoost and Wilson Electronics, LLC

Wilson Electronics, LLC, home of WilsonPro and weBoost, is a market leader in cellular signal booster technology, dedicated to delivering wireless network coverage to everyone, everywhere. Each booster is FCC approved to amplify signal from all major carriers for all cellular devices, significantly improving cellular coverage in homes, vehicles and commercial buildings. The company has developed and manufactured cell phone signal boosters, antennas and related components for more than 20 years—establishing an extensive portfolio of intellectual property surrounding mobile phone repeater and booster architectures along the way. All Wilson Electronics products are designed, assembled, and tested in the USA. For more information, visit www.weboost.com.

The Link Lonk


March 31, 2021 at 07:00PM
https://ift.tt/39vwCMR

Wilson Electronics Announces Most Powerful RV Cell Booster on the Market - the weBoost Destination RV - Business Wire

https://ift.tt/2DVP6sH

Will we need annual COVID-19 shots, or booster shots? Maybe. - Press Herald


As Mainers line up to get their COVID-19 shots this spring, scientists are studying whether we will have to undergo future coronavirus vaccinations. The keys to determining the need for annual shots or booster shots are how long immunity lasts and how well the vaccines perform against variants.

The answers to those questions will decide whether we will be heading to mass vaccination sites and pharmacies for COVID-19 shots in 2022, 2023 and beyond.

Will the COVID-19 shot be like an annual flu shot, or a periodic shot that you get every two, three or five years? Or will you get the COVID-19 vaccine once and not have to get it again?

The answer is a resounding “maybe.”

“The immunity likely won’t last a lifetime,” said Joshua Michaud, associate director of global health policy for the Kaiser Family Foundation, a Washington-based health policy research center. “We know there’s a robust immune response to severe infection that lasts at least nine months. Vaccine immunity does wane over time, but we don’t know how fast that will happen or to what extent it will happen.”

A vaccine study by the Veterans Administration that soon will be released shows the vaccines offer at least seven to nine months protection, and likely longer, according to the military.com website.

Michaud said the vaccines work extremely well at preventing disease, and there’s increasing evidence the vaccines also prevent transmission of COVID-19. If there’s less transmission, the virus has fewer chances to replicate and create new variants that might reduce the effectiveness of the vaccines.

He said because scientists know the vaccines produce a strong immune response for at least nine months in real-world usage – that’s the time since the vaccines were first administered in later-stage clinical trials – that means the vaccines could maintain protection in people for much longer. But it’s not yet known how long immunity will last.

Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, said the vaccines are a “stunning scientific success story,” but it’s still possible booster shots or annual COVID-19 shots will be needed.

“There are reasons we might see a yearly COVID shot. It’s too early to tell,” Shah said in a media briefing with reporters on Tuesday. “Cold and flu season in subsequent years might become known as COVID and flu season.”

Another possibility is a periodic booster shot, perhaps once every three to five years. Vaccine manufacturers are already researching potential booster shots.

Dr. Dora Anne Mills, chief health improvement officer for MaineHealth, the parent company of Maine Medical Center in Portland, said the booster shots could serve a dual role, to protect against variants and to boost immunity to COVID-19. Seniors may need to be prioritized for booster shots because their immune systems are weaker and immunity may wane sooner in seniors, she said.

“We know from many other vaccines that we need a boost every once in a while,” Mills said, pointing to booster shots in middle and high school for some childhood vaccinations, and for adults, a tetanus shot once every 10 years.

The booster shots will be different than for the annual flu shot – and could potentially offer protection for much longer than the flu shot – because the novel coronavirus mutates much more slowly than flu viruses, Mills said.

But the novel coronavirus does mutate.

So one of the ways to keep vaccines working well is to ramp up manufacturing of vaccines and distribute them worldwide, which helps clamp down on variants. Scientists are worried that Brazil, which is dealing with rampant infections and low vaccine supply, and is the source of one of the variants, P1, could be a source of variants for years to come.

“We have to help vaccinate the world,” Mills said. “We are not going to be safe until there is reduced transmission around the world.”

Michaud said while there’s been a lot of discussion about variants – with P1 being a particular focus because early research shows it may reduce vaccine effectiveness – the vaccines likely will still provide strong protection. The vaccines work well against other common variants, including the one from the United Kingdom and a mutation first discovered in South Africa.

He said the P1 variant and future mutations that diminish vaccine function will more likely “chip away at the edges” of vaccine effectiveness rather than completely escape the immune response vaccines create.

“It’s important to know the extent to which the variant evades immunity, and that we don’t have a real good handle on it (for P1),” Michaud said. “How much vaccine evasion is too much? That is to be determined.”

Michaud said another factor is that lab studies that examine COVID-19 antibody production to determine whether the virus is evading the vaccine do not take into account the full immune response, which is much more complicated than what can be done in a lab.

Dr. Monica Gandhi, an infectious disease expert from the University of California San Francisco, said in a March 21 tweet that promising early research shows that the body’s full immune response after vaccination is working to protect people from COVID-19. She said antibodies are only the “tip of the iceberg” in how the body responds to invading viruses.

“The public focus on (variants) detracts from realizing how amazing these vaccines are,” Gandhi said.

Michaud said one way scientists are looking at a permanent solution to COVID-19 and future variants is to create a “universal vaccine” that would work against all variants.

“The holy grail of the coronavirus vaccine, the universal vaccine, would be effective against all current variants and future variants. The universal vaccine would target parts of the coronavirus that don’t mutate very much,” Michaud said. “Some people think we can get there.”

But Michaud said while studies are underway on a universal vaccine, it may not happen.

“They have been trying to develop a universal influenza vaccine for decades, and it always seems to be another decade away from happening,” he said.


Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.

filed under:
The Link Lonk


March 31, 2021 at 04:29AM
https://ift.tt/3ue72nr

Will we need annual COVID-19 shots, or booster shots? Maybe. - Press Herald

https://ift.tt/2DVP6sH

Wade Hampton High School booster club member charged with stealing funds, warrant says - WYFF4 Greenville


A member of the Wade Hampton High School Band Booster organization has been charged with a breach of trust.According to the arrest warrant, Rhonda Kay Clawson, 47, of Greenville, was charged with a breach of trust with fraudulent intent of $10,000 or more.The warrant said BB&T bank documents and various store surveillance video, and other evidence shows Clawson depleted the funds in the school's booster club in excess of $10,000.Clawson has withdrawn from numerous ATMs as well as spent money on items for personal benefit on the BB&T debit card that was entrusted to here from the Wade Hampton High School Booster Club, the warrant said.In an email sent to parents Tuesday from the school's principal Dr. Carlos C. Grant, he said the school was cooperating with law enforcement."Though the Band Boosters are an independent organization without direct oversight from WHHS or GCS, we are cooperating fully with the investigation," Grant wrote."The discrepancy in the Band Booster accounts was discovered by a member of our staff and immediately brought to the attention of law enforcement who has been conducting an investigation into these concerns for the past several weeks," Grant said. Grant said the school will work within the legal system to retrieve for the band program as many of the missing funds as possible.

A member of the Wade Hampton High School Band Booster organization has been charged with a breach of trust.

According to the arrest warrant, Rhonda Kay Clawson, 47, of Greenville, was charged with a breach of trust with fraudulent intent of $10,000 or more.

Advertisement

The warrant said BB&T bank documents and various store surveillance video, and other evidence shows Clawson depleted the funds in the school's booster club in excess of $10,000.

Clawson has withdrawn from numerous ATMs as well as spent money on items for personal benefit on the BB&T debit card that was entrusted to here from the Wade Hampton High School Booster Club, the warrant said.

In an email sent to parents Tuesday from the school's principal Dr. Carlos C. Grant, he said the school was cooperating with law enforcement.

"Though the Band Boosters are an independent organization without direct oversight from WHHS or GCS, we are cooperating fully with the investigation," Grant wrote.

"The discrepancy in the Band Booster accounts was discovered by a member of our staff and immediately brought to the attention of law enforcement who has been conducting an investigation into these concerns for the past several weeks," Grant said.

Grant said the school will work within the legal system to retrieve for the band program as many of the missing funds as possible.

The Link Lonk


March 31, 2021 at 05:10AM
https://ift.tt/2Ob44AI

Wade Hampton High School booster club member charged with stealing funds, warrant says - WYFF4 Greenville

https://ift.tt/2DVP6sH

Woman sentenced for booster club theft - WNEP Scranton/Wilkes-Barre


FACTORYVILLE, Pa. — The former treasurer of a booster club in Lackawanna County was sentenced for theft.

In a virtual hearing, Linda Fauquier received three months of house arrest and 200 hours of community service.

In December, she pleaded guilty to taking money from Lackawanna Trail's Booster Club.

Her attorneys say she paid the booster club $20,000 this week. 

Faquier also apologized to the players and families affected by the theft.

The Link Lonk


March 31, 2021 at 04:33AM
https://ift.tt/3rLBMKZ

Woman sentenced for booster club theft - WNEP Scranton/Wilkes-Barre

https://ift.tt/2DVP6sH

Tuesday, March 30, 2021

High school's booster club president accused of stealing more than $10K from account, deputies say - FOX Carolina


TAYLORS, SC (FOX Carolina) - The former President of the Wade Hampton High School Booster Club has been arrested after she was accused of stealing money from the Booster Club's bank account, according to the Greenville County Sheriff's Office and Greenville County Schools.

Deputies said they began investigating on March 11 after officials discovered questionable charges made to the banc account.

"Our investigation led to the discovery that 47 year-old Ronda Kay Clawson, who was the President of the Booster Club, was responsible for these charges and investigators have since charged her with Breach of Trust greater than $10,000," Lt. Ryan Flood stated in an email.

According to the arrest warrant, Clawson is accused of withdrawing money from multiple ATMs using the debit card she was issued by the Booster Club. 

Greenville County Schools spokesman Tim Waller released this statement:

"We can confirm that a member of the Wade Hampton High School Band Boosters organization has been charged with Breach of Trust related to funds that are missing from the organization’s accounts.  This individual does not work for Greenville County Schools. Though the Band Boosters are an independent organization without direct oversight from GCS, we are cooperating fully with the investigation and will work within the legal system to retrieve for the band program as many of the missing funds as possible."

Clawson was booked into the county jail on Tuesday.

MORE NEWS - IRS says stimulus payments for non-filing Social Security recipients should start going out later this week

The Link Lonk


March 31, 2021 at 01:52AM
https://ift.tt/3m6NApB

High school's booster club president accused of stealing more than $10K from account, deputies say - FOX Carolina

https://ift.tt/2DVP6sH

exocad Announces Roll-Out Of DentalCAD 3.0 Galway - The Productivity Booster With Instant Anatomic Morphing - PRNewswire


"We have systematically analyzed, in which steps dental technicians around the world spend the most time on during restorative design," said Tillmann Steinbrecher, exocad CEO. "Based on the extensive analysis, we developed technologies such as the new Instant Anatomic Morphing, which enables users to reduce design time by as much as 20-30%, on average*."

"Thanks to the advanced process automation, dental technicians will get from the automatic proposal to their individual design goal faster, as the anatomy of teeth is adjusted in real-time with each movement, resulting in a major increase in productivity."- added Steinbrecher.

With the new Galway release, exocad additionally introduced AI technology for its Smile Creator. Facial features are automatically detected to achieve an esthetic proposal faster to save valuable time when designing cases. Another new feature offers printable clip-on mockups of the planned anatomic result. Instead of a purely visual representation of the smile makeover on screen, patients can physically experience their new smile with try-ins, resulting in higher patient engagement and opening up new possibilities in consultation.

Inspired by Google Material Design, DentalCAD 3.0 Galway comes with a new, modern user interface and improved integration with exoplan, exocad's implant planning software. All features of the new release are built to improve ease of use in CAD design and to expand the possibilities of digital dentistry.

With this new release, exocad introduces 90 new and 80 optimized features. Key highlights of DentalCAD 3.0 Galway include:

  • New Instant Anatomic Morphing for reduced design time and increased productivity
  • AI-assisted technology for Smile Creator: facial features are automatically detected for faster smile design
  • Parametric shape adjustment: all tooth libraries are continuously adjustable from a newer to an older anatomy, seamlessly applying natural abrasion to all selected teeth
  • New and modern exocad user interface, offering a user-centric design to make digital interaction as fluid, intuitive and efficient as possible
  • New tools for easy and intuitive controlling of the individual path of insertion
  • Improved bridge connector editing with split screen view and tools to change several connectors at once, for a faster workflow in every anatomic situation
  • Mockup tooth setups for improved patient communication. Clip-on try-ins, wax-up models, virtually prepared models and virtual tooth extractions are now supported
  • Model Creator now supports conical stump dies for easier fitting even with lower accuracy printers
  • Bite Splint Module can now add anatomic shapes directly to the designed bite splints

DentalCAD 3.0 Galway is available immediately worldwide and can be accessed by all users with a valid upgrade contract. exocad names its releases after current "European Capitals of Culture" and selected the Irish city of Galway for this release.

Additional information is available at exocad.com/dentalcad-galway

*User test performed in February 2020. Data on file.

About exocad GmbH
exocad GmbH, an Align Technology, Inc. company, is a dynamic and innovative software company committed to expanding the possibilities of digital dentistry and providing OEMs (Original Equipment Manufacturers) with flexible, reliable, and easy-to-use CAD/CAM software for dental labs and dental practices. exocad software has been chosen by leading OEMs worldwide for integration into their dental CAD/CAM offerings, and thousands of exocad DentalCAD licenses are sold each year. For more information and a list of exocad reseller partners, please visit exocad.com.

SOURCE exocad GmbH

The Link Lonk


March 31, 2021 at 12:45AM
https://ift.tt/3czmVPa

exocad Announces Roll-Out Of DentalCAD 3.0 Galway - The Productivity Booster With Instant Anatomic Morphing - PRNewswire

https://ift.tt/2DVP6sH

New Yorkers need a morale booster after COVID-19, but 57% are optimistic about the city's future - amNY


Sign up for our PoliticsNY newsletter for the latest coverage and to stay informed about the 2021 elections in your district and across NYC

How are New Yorkers feeling about the future of the metro region as the yoke of COVID-19 appears to nearly be lifted?

A study from the Regional Plan Association shows that optimism is blooming, but when demographics come into play there may be differences in these feelings based on the specific background of the New Yorkers surveyed by the group with Black, Hispanic and low-income residents feeling the most apprehension.

Kate Slevin, Senior Vice President, State Programs and Advocacy for the Regional Plan Association, said much of this can be attributed to the system being stacked against these groups long before the virus became a reality.

“Different groups in our region were hit by the pandemic in different ways, and structural inequality was visible in the poll results,” Slevin said. “Women and people of color were less satisfied, less optimistic, and more likely to have been more severely affected by COVID. Still, 57% of people are optimistic about our future as we recover from COVID-10. The question now is – will the city and region be able to address some of these longstanding inequalities and recover in a more equitable way?”

For the remaining 43%, according to the RPA, the same old New York problems of how they are going keep a roof over their head or even find a roof to begin with still linger.

“The cost of living, especially housing, remains a huge concern for residents of the region,” Slevin added. “These numbers show residents throughout the region are experiencing a key inflection point in our recovery, and are proof of the resiliency tri-state residents have shown time and time again.”

Global Strategy Group conducted the survey on behalf of the RPA and interviewed 800 adults in the New York metropolitan region and found that people of color were significantly less enthusiastic about how their quality of life will improve in the coming months and years compared men; especially white residents and people making over $100k a year.

“Despite the challenges of the past year, this poll demonstrates the resiliency of residents in our region,” Tom Wright, President of Regional Plan Association, said. “While we’re optimistic about the region’s future, the discrepancies among different groups is a crucial reminder that the pandemic affected people differently.”

Some findings from the survey from the RPA are as follows:

  • The high cost of living, crime, and high taxes are perceived as the biggest threats to the metropolitan area. Discrepancies among demographics are also prevalent in this area. Black and women respondents were more likely to select housing un-affordability and high cost of living as the biggest threats. Latinx respondents were more likely to cite crime, and white respondents were more likely to select high taxes.
  • Jobs and the economy are top issues New York metro residents want their leaders to focus on. This was particularly a priority for Black and low-income residents.
  • The majority of New Yorkers believe the worst of the pandemic is over. Only a quarter say the worst is yet to come, but Latinx residents and parents are more likely to have a more pessimistic outlook.
  • Most respondents believe quality of life will improve in the years to come. More than half of New Yorkers, however, say they would move out of their community if they could (52% would move/48% would stay), a noticeable increase since RPA surveyed residents in 2013 (36% would move/62% would stay).
  • A vast majority agree life has been difficult during the pandemic, and many were personally affected. While three in four New Yorkers agree that life has been difficult since the coronavirus pandemic began (75% difficult/25% not difficult), Black residents (82% difficult/15% not difficult), Asian-American residents (77% difficult/21% not difficult) and residents making less than $50,000 (82%difficult/15% not difficult) are the most likely to say life has been difficult.
  • In addition to health, social isolation, lack of jobs, home payments, and food were other challenges residents faced during the pandemic. While white residents (62%) are more likely than adults overall to say that social isolation is their largest source of stress, Black residents are more likely to point to rent or home payments (48%) and access to food (20%) as their largest sources of stress, and Latinx residents point to lack of a job/job security (37%) and rent or home payments (39%). White residents are more likely to point to social isolation (51%). New York City residents (30%) are more likely than residents outside of New York City (22%) to say rent or home payments are the largest source of stress.

View a memo detailing the data compiled by Global Strategy Group by following this link.

The Link Lonk


March 31, 2021 at 03:00AM
https://ift.tt/3mhuEF3

New Yorkers need a morale booster after COVID-19, but 57% are optimistic about the city's future - amNY

https://ift.tt/2DVP6sH

Britain says COVID variant booster ready by September - WALB


[unable to retrieve full-text content]Britain says COVID variant booster ready by September  WALB The Link Lonk


March 27, 2021 at 08:08PM
https://ift.tt/3dhJDKN

Britain says COVID variant booster ready by September - WALB

https://ift.tt/2DVP6sH

Monday, March 29, 2021

East Bay Company Creating Booster Shot to Protect Residents From COVID-19 Variants - NBC Bay Area


If 2021 was the year when most of America got vaccinated against COVID-19, 2022 might be the year of the COVID-19 booster shot. 

Gritstone Oncology Inc. is the Emeryville company that’s creating a second generation COVID vaccine. CEO Dr. Andrew Allen says the goal is to create a booster shot that protects people from evolving coronavirus variants. 

“Everyone has heard about the UK variant, the South Africa variant,” said Allen. “We want to generate immunity that is effective across all these variants so that we stop having to worry about it quite as much as we do know.”

Testing is underway. A group of 100 people have received the booster shot, as part of a Phase One trial. 

“It’s a wide range of folks,” said Allen. “The National Institute of Health is running this study, so this is Dr. Fauci’s team at NIAID.”

So who would benefit most from these COVID-19 booster shots? NBC Bay Area posed that question to Dr. Lee Riley, who studies infectious diseases at UC Berkeley. 

“I think at risk groups such as people who have underlying medical conditions, immunosuppressive conditions, older individuals, they may need boosters sooner,” said Riley. 

Allen said he doesn't yet know if they would be a once-a-year booster shot or one and done. He says ongoing research will answer that question sometime by next year, when he anticipates the booster shot will be ready for FDA approval. 

“We’re not out of the woods yet, I hope we’ll get there soon. The first generation vaccines are a fantastic beginning but I don’t think the story is complete at this point,” he said.

The Link Lonk


March 30, 2021 at 08:50AM
https://ift.tt/39qcX0O

East Bay Company Creating Booster Shot to Protect Residents From COVID-19 Variants - NBC Bay Area

https://ift.tt/2DVP6sH

Booster Appoints VP of Account Management as Its Customer Base Doubles - PRNewswire


"As Booster's fleet and consumer businesses both grow, bringing Ericka to our executive team will help us enormously," said Frank Mycroft, CEO and co-founder of Booster. "We always want our customers to have positive experiences, and Ericka's background supporting enterprise clients at large-scale logistics companies will enable us to make sure they do. Ericka will also be pivotal as we launch services in new markets and diversify our product offerings this year."

In her newly created role, Ramon will lead a team managing all aspects of client support for the fleet and consumer businesses.

"I am thrilled to be joining such a phenomenal company as part of its executive team," said Ramon. "Booster is transforming energy delivery, and customers realize the benefits of the innovation and efficiencies we provide. I look forward to accelerating client growth and partnership efforts here."

With the addition of Ramon, Booster rounds out a number of recent additions to the company's senior leadership, including Austin Brizgys as Vice President of Marketing and Sales, John Tokash as Vice President of Engineering, Bobby Greene as Senior Director of Fleet, Jordan Valdés as Head of Public Affairs, and Jason Anello as Head of Design Experience.

Images: https://drive.google.com/drive/folders/1ftdkJAoe8MeWc01aQzc16K_T3OSHDrMn?usp=sharing

About Booster Fuels
Named a Forbes 2021 Best American Startup Employers, Booster is the leading same-day fuel delivery service focused on reinventing the way energy is delivered. The company established the category and has reimagined traditional energy supply chain logistics to bring gas stations directly to business fleets and consumers with the tap of an app, preventing 1.1 pounds of CO2 with each boost delivered. Booster operates in seven major markets and has received permits to operate in more than 150 jurisdictions across the U.S.

The company has raised more than $88 million in funding from firms such as Invus Opportunities, Conversion Capital, Enterprise Holdings Ventures, Madrona Venture Group, Maveron, Perot Jain LP, Total Ventures, and Vulcan Capital. Booster's corporate clients have included Facebook, PayPal, eBay, and Cisco, among others. For more information, visit  www.trybooster.com.

Media Contact for Booster Fuels:
Erica Zeidenberg
Hot Tomato for Booster
[email protected]
925.518.8159

SOURCE Booster Fuels, Inc

The Link Lonk


March 29, 2021 at 09:00PM
https://ift.tt/2PgbP90

Booster Appoints VP of Account Management as Its Customer Base Doubles - PRNewswire

https://ift.tt/2DVP6sH

Sunday, March 28, 2021

Britain says COVID variant booster ready by September - WWNY


[unable to retrieve full-text content]Britain says COVID variant booster ready by September  WWNY The Link Lonk


March 27, 2021 at 08:08PM
https://ift.tt/3u2o6MV

Britain says COVID variant booster ready by September - WWNY

https://ift.tt/2DVP6sH

Sinopharm needs trial results to decide if COVID-19 vaccine needs booster shot: executive - Reuters


BEIJING (Reuters) - China National Pharmaceutical Group (Sinopharm) will need to assess results from overseas Phase III clinical trials to decide whether its two-shot COVID-19 vaccine should be followed by a booster shot, a company executive said on Sunday.

FILE PHOTO: A health worker counts used vials of Sinopharm's coronavirus disease (COVID-19) vaccine, at a vaccination centre in Karachi, Pakistan February 11, 2021. REUTERS/Akhtar Soomro/File Photo

Regulators and vaccine developers are looking at whether booster doses are necessary amid concerns that emerging variants of the new coronavirus might weaken protection of vaccines designed against older strains.

“The preliminary results so far showed that the booster vaccination can effectively increase the neutralizing antibody titer and antibody persistence, and also effectively improve the vaccine’s ability to resist mutations,” Zhang Yuntao, vice president at China National Biotec Group (CNBG), an affiliate of Sinopharm, said on Sunday.

“Is a booster shot needed? When will the booster be given? The answer should be based on the results of future phase III clinical studies,” Zhang said at a news conference.

Antibodies triggered by two COVID-19 vaccine products from Sinopharm both have “pretty good” neutralising effect on variants found in Britain and South Africa as well as a few others, Zhang told a news conference, citing results from lab tests using blood samples taken from clinical trial participants.

Lab testing was ongoing for variants found in Brazil and Zimbabwe, Zhang said.

The effect of antibodies induced by Sinovac Biotech’s vaccine declined against a variant identified in South Africa, while the effect against a variant found in Britain remained similar to that against the older Wuhan variant, Gao Qiang, general manager at Sinovac unit Sinovac Life Sciences, said during the same presser.

Sinovac is importing the variant from Brazil for vaccine research and development, and work tailored to the South Africa variant had already started, Gao said.

The correlation between antibody levels and the vaccine’s efficacy was not immediately clear, a Sinovac spokesman said.

Sinovac was also testing a third booster shot in a China-based clinical trial, with participants given a third dose around eight months after receiving the second, the company said on Tuesday.

The South Africa variant could pose a greater threat than others based on antibody responses triggered by the vaccine from CanSino Biologics Inc (CanSinoBIO), a company executive said earlier this month. Antibodies triggered by one dose of CanSinoBIO’s vaccine showed a roughly four-fold drop in their ability to block the 501Y.V2 variant, the firm’s chief scientific officer, Zhu Tao, said. The weakening effect by other variants fell into a less severe range, he added.

Reporting by Roxanne Liu and Ryan Woo; Editing by Simon Cameron-Moore and Stephen Coates

The Link Lonk


March 28, 2021 at 02:44PM
https://ift.tt/2Phsx7M

Sinopharm needs trial results to decide if COVID-19 vaccine needs booster shot: executive - Reuters

https://ift.tt/2DVP6sH

Sinopharm needs trial results to decide if COVID-19 shot needs booster: executive - Reuters


BEIJING (Reuters) - China National Pharmaceutical Group (Sinopharm) will need to assess results from overseas Phase III clinical trials to decide whether its two-shot COVID-19 vaccine should be followed by a booster shot, a company executive said on Sunday.

FILE PHOTO: A health worker counts used vials of Sinopharm's coronavirus disease (COVID-19) vaccine, at a vaccination centre in Karachi, Pakistan February 11, 2021. REUTERS/Akhtar Soomro/File Photo

Regulators and vaccine developers are looking at whether booster doses are necessary amid concerns that emerging variants of the new coronavirus might weaken protection of vaccines designed against older strains.

“The preliminary results so far showed that the booster vaccination can effectively increase the neutralizing antibody titer and antibody persistence, and also effectively improve the vaccine’s ability to resist mutations,” Zhang Yuntao, vice president at China National Biotec Group (CNBG), an affiliate of Sinopharm, said on Sunday.

“Is a booster shot needed? When will the booster be given? The answer should be based on the results of future phase III clinical studies,” Zhang said at a news conference.

Antibodies triggered by two COVID-19 vaccine products from Sinopharm both have “pretty good” neutralising effect on variants found in Britain and South Africa as well as a few others, Zhang told a news conference, citing results from lab tests using blood samples taken from clinical trial participants.

Lab testing was ongoing for variants found in Brazil and Zimbabwe, Zhang said.

The effect of antibodies induced by Sinovac Biotech’s vaccine declined against a variant identified in South Africa, while the effect against a variant found in Britain remained similar to that against the older Wuhan variant, Gao Qiang, general manager at Sinovac unit Sinovac Life Sciences, said during the same presser.

Sinovac is importing the variant from Brazil for vaccine research and development, and work tailored to the South Africa variant had already started, Gao said.

The correlation between antibody levels and the vaccine’s efficacy was not immediately clear, a Sinovac spokesman said.

Sinovac was also testing a third booster shot in a China-based clinical trial, with participants given a third dose around eight months after receiving the second, the company said on Tuesday.

The South Africa variant could pose a greater threat than others based on antibody responses triggered by the vaccine from CanSino Biologics Inc (CanSinoBIO), a company executive said earlier this month. Antibodies triggered by one dose of CanSinoBIO’s vaccine showed a roughly four-fold drop in their ability to block the 501Y.V2 variant, the firm’s chief scientific officer, Zhu Tao, said. The weakening effect by other variants fell into a less severe range, he added.

Reporting by Roxanne Liu and Ryan Woo; Editing by Simon Cameron-Moore and Stephen Coates

The Link Lonk


March 28, 2021 at 02:44PM
https://ift.tt/3rrSAGt

Sinopharm needs trial results to decide if COVID-19 shot needs booster: executive - Reuters

https://ift.tt/2DVP6sH

Saturday, March 27, 2021

COVID Vaccine Updates: Booster shots may be needed until infections die down, study suggests - WABC-TV


NEW YORK (WABC) -- Just like flu vaccines, which are adjusted each year to combat viruses as they change and mutate, COVID-19 vaccines may need similar alterations until infection rates decrease, a recent study suggests.

A team of researchers from a German research hospital found that four common cold coronaviruses that infect humans by the same spike protein mechanism that SARS-CoV-2 uses do evade the immune system just like the influenza virus.

But, researchers say a good sign for COVID-19 is that the coronaviruses evolved about four times slower than flu viruses.

Still, SARS-CoV-2 is mutating at a faster rate than the coronaviruses in the study and likely won't slow down until the rate of infections across the globe drops dramatically.

So, vaccine producers such as Moderna, Pfizer, AstraZeneca, and Johnson & Johnson are already working on boosters for their vaccines to be more effective against variants.

What to know about coronavirus:

Tracking COVID-19 availability and progress in NYC


New Jersey COVID-19 Vaccine Tracker
Find out if you are eligible and where you can go to get your vaccine
Coronavirus by zip code - New York City
Do you have coronavirus symptoms?
national geographic covid newsletter sign up

Here are more of today's headlines:

NY, CT among 22 states with more than 10% increase in new cases
New York and Connecticut are among 22 states that have seen a more than 10% increase in the number of new cases week on week, new data from the Department of Health and Human Services shows. Meanwhile, New York and Connecticut are joined by New Jersey on the list of states with the highest case rates nationally (7 day daily average: 310, 225, and 321 per 100k population, respectively). Among these states, New Jersey had the highest RT-PCR test positivity in the last seven days (8.8%).

Increasing cases in Connecticut
The Connecticut State Department of Public Health is reminding residents to remain vigilant against COVID-19 as case rates have risen over the last two weeks.

DPH has moved several Connecticut towns that had been seeing falling or stable COVID-19 case rates back into Red Alert status, as the average daily case rate for COVID-19 has increased statewide to 25 cases/100,000 residents per day.

Over 90% of the Connecticut population lives in a town with an average daily case rate of over 15 cases per 100,000 residents. It is estimated that 40% of these new cases are the B.1.1.7 variant.

Fauci lays out scenario for when experts could loosen face mask recommendations
If a new study shows that vaccinations prevent COVID-19 transmission, inoculated Americans could be "much more liberal" in deciding whether or not to wear a face mask, said Dr. Anthony Fauci, the top U.S. infectious disease expert.

But he also said that he cannot start recommending the removal of face masks until daily COVID infections reduce drastically.

NJ Transit vaccinating bus drivers, transit workers
New Jersey Transit bus drivers and transit workers will receive COVID-19 vaccinations on Saturday. All of the state's public transit workers first became eligible on March 15. At least 21 NJ Transit employees have died of complications from coronavirus -- including 11 bus drivers and one train operator.

1st priest in US to die of COVID remembered
Father Jorge Ortiz-Garay, a Mexican-born Brooklyn pastor, became the first priest in the United States to die as a result of COVID-19.

Bishop Nicholas DiMarzio will lead memorial mass in Bushwick, Brooklyn, at St. Brigid Church on Saturday.

5,000 attend rock concert in Barcelona after COVID-19 screen
Five thousand music lovers are set to attend a rock concert in Barcelona after passing a COVID-19 screening, to test its effectiveness in preventing outbreaks at large cultural events.

The show on Saturday has the permission of Spanish health authorities. Concertgoers will undergo an antigen test hours before the concert.

Those who test negative will be able to attend the indoor concert and mix freely, although face masks will be mandatory. The concert is an expanded version of a case study in December based on a concert for 500 people that organizers said showed no sign of contagion.

NYC COVID tracing initiative


NYC is devoting $600 million toward its COVID tracing initiative. More tracers were hired over the first two weeks of March as cases surged in the post-holiday period.

Because of the renewed effort, the city was able to hit its goal of reaching at least 90% of people who tested positive -- a goal it hadn't achieved since around Thanksgiving.

NY unveils digital 'Excelsior' pass to help businesses, venues reopen
New York Governor Andrew Cuomo on Friday announced the launch of Excelsior Pass, a free and voluntary platform developed in partnership with IBM that utilizes secure technology to confirm an individual's recent negative PCR or antigen test result or proof of vaccination. The goal is to help fast track the reopening of businesses and event venues in accordance with state Department of Health guidelines.
Similar to a mobile airline boarding pass, individuals will be able to either print out their pass or store it on their smartphones using the Excelsior Pass Wallet app. Each Pass will have a secure QR code, which participating businesses and venues can scan using a companion app to verify proof of COVID-19 negative test results or proof of vaccination.

Spurred by lockdown, Spain gives 4-day week a try
Experimenting with cutting back one workday per week is about to go nationwide in Spain. A three-year pilot project will be using 50 million euros ($59 million) from the European Union's massive coronavirus recovery fund to compensate companies as they resize their workforce or reorganize production workflows to adapt to a 32-hour working week.

While several companies have already embraced the trend, the pandemic has accelerated it. Supporters say that shorter schedules could benefit work-life balance and three-day weekends could boost consumption. But critics argue that a pandemic-shaken economy is no ground for experiments.

Israelis gather for Passover, celebrating freedom from virus
Israelis will once again hold large family gatherings this weekend to celebrate Passover, the festive Jewish holiday recalling the biblical flight of the Israelites from Egypt.

That's thanks to a highly successful coronavirus vaccination campaign that has inoculated 80% of the country's adult population. Authorities have reopened restaurants, hotels, museums and theaters, and permit indoor gatherings of up to 20 people. It's a stark turnaround from last year, when Israel was in its first of three lockdowns, with people largely confined to their homes.

China outlines COVID-origin findings, ahead of WHO report
Chinese officials briefed diplomats Friday on the ongoing research into the origin of COVID-19, ahead of the expected release of a long-awaited report from the World Health Organization.

The briefing appeared to be an attempt by China to get out its view on the report, which has become enmeshed in a diplomatic spat. The U.S. and others have raised questions about Chinese influence and the independence of the findings, and China has accused critics of politicizing a scientific study.

When did you realize the COVID pandemic changed everything?
Many of us had a moment, most often occurring in March 2020, when we realized that COVID-19 had completely changed our lives forever. Even though we've managed to move forward and adapt to a new normal, that memory still sticks with us. Tell us: What was that moment to you?


Top 7 COVID vaccine questions answered
You had questions about COVID-19 vaccines and 7 On Your Side is getting you answers from doctors on the front line of the pandemic.

MORE CORONAVIRUS COVID-19 COVERAGE


Positive COVID-19 cases by zip code - New York City
New York City COVID-19 Vaccine Tracker
New Jersey COVID-19 Vaccine Tracker
Find out if you are eligible and where you can go to get your vaccine
Do you have coronavirus symptoms?
Where to get tested in New York, New Jersey and Connecticut
WATCH: Eyewitness to a Pandemic
Centers for Disease Control and Prevention on coronavirus
Submit a News Tip or Question
aa

Copyright © 2021 WABC-TV. All Rights Reserved.

The Link Lonk


March 28, 2021 at 04:00AM
https://ift.tt/39m8pZ8

COVID Vaccine Updates: Booster shots may be needed until infections die down, study suggests - WABC-TV

https://ift.tt/2DVP6sH

Britain says COVID variant booster ready by September - WWBT NBC12 News


[unable to retrieve full-text content]
  1. Britain says COVID variant booster ready by September  WWBT NBC12 News
  2. At-risk UK groups could get Covid booster shots from September  The Guardian
  3. UK plans COVID-19 vaccine boosters for people over-70s from September - The Telegraph  Reuters
  4. Newspaper headlines: 'Over-70s autumn booster' and shops 'open till 10'  BBC News
  5. COVID-19: Booster shots could start in September for over-70s, says vaccines minister  Sky News
  6. View Full Coverage on Google News
The Link Lonk


March 27, 2021 at 08:08PM
https://ift.tt/3suyf4N

Britain says COVID variant booster ready by September - WWBT NBC12 News

https://ift.tt/2DVP6sH

Covid: England lockdown easing still on course, says PM - BBC News


[unable to retrieve full-text content]
  1. Covid: England lockdown easing still on course, says PM  BBC News
  2. Covid booster shots could begin in September for over-70s, says vaccine minister  Wales Online
  3. Exclusive: Over-70s to get booster Covid vaccines from September  MSN UK
  4. Vaccines minister says booster shots could begin in September for over-70s  Leigh Journal
  5. View Full Coverage on Google News
The Link Lonk


March 28, 2021 at 12:39AM
https://ift.tt/39jJ4iv

Covid: England lockdown easing still on course, says PM - BBC News

https://ift.tt/2DVP6sH

The Latest: Britain says variant booster ready by September - Minneapolis Star Tribune


ISTANBUL — Turkey will begin vaccinating people over 60 and some risk groups as daily infections climb, the country's health minister says.

Minister Fahrettin Koca announced on Twitter the spouses of people above 60 are also eligible. The risk groups included in this round of vaccinations are people with underlying conditions.

Turkey rolled out its vaccination program in January with CoronaVac by Chinese biopharmaceutical company Sinovac and has administered more than 14.6 million shots. This week, the country also received approximately 1.4 million doses of the Pfizer vaccine.

Daily infections reached more than 30,000 Saturday as Turkey continues with relaxed restrictions. Another 151 new deaths were registered, bringing the total confirmed death toll to 30,923.

___

THE VIRUS OUTBREAK:

— Brazil daily deaths near 4,000, worst may lie ahead

— Countries neighboring Serbia flock for coronavirus vaccine

— Israelis gather for Passover, celebrating freedom from virus

— Shots and a musical serenade at NYC vaccination center

___

— Follow AP's pandemic coverage at https://ift.tt/35k8pHx, https://ift.tt/3ajhaVd and https://ift.tt/2wrCaXK

___

HERE'S WHAT ELSE IS HAPPENING:

HONOLULU — Weddings on Oahu in Hawaii can be held outside with a maximum of 100 people after an easing of public health orders related to the coronavirus pandemic.

Honolulu Mayor Rick Blangiardi says the easing of the 10-person wedding restriction is effective immediately. A limit of 10 people will continue for indoor weddings.

For outdoor weddings, all must wear face masks and each wedding must be supervised by "event planning professionals." Temperature checks will be required.

The news was applauded by members of the state's wedding industry, which was dramatically affected by the pandemic.

___

BIRMINGHAM, Ala. — The confusing maze of websites and phone numbers required to sign up for an COVID-19 immunization in the U.S. is presenting a challenge for people who are visually impaired or hard of hearing.

Providers are using different systems that can vary by state and even cities. The blind and deaf says that often forces them to rely from others to help them get in line.

In Oregon, Carla McQuillan can't see and couldn't use screen reader to make an appointment. Dante Little says he helped 20 disabled people in Alabama who couldn't otherwise get shots.

The CDC reports an estimated 12 million Americans over age 40 have impaired vision, including 1 million who are blind. The National Association of the Deaf says a 2011 study found 48 million Americans are deaf or hard of hearing.

___

BERLIN — Health Minister Jens Spahn says Germany needs a strict lockdown last at least 10-14 days to reduce the rapid rise of coronavirus infections, which has been fueled by a more contagious variant.

The country's disease control agency announced 20,472 newly confirmed cases of COVID-19 and 157 additional deaths on Saturday. The head of the Robert Koch Institute said Friday that Germany could see as many as 100,000 infections daily if infections keep rising exponentially.

This week, the governors of Germany's 16 states resisted imposing stricter rules demanded by medical experts. Some states have also refused to implement an "emergency brake" previously agreed with Chancellor Angela Merkel when weekly case numbers rise above 100 per 100,000 inhabitants.

Spahn said at a public meeting Saturday, "if we look at the numbers, including the developments today, we need another 10-14 days, at least, of properly driving down contacts and movements, a lockdown if you want to call it that, like we had for Easter last year."

___

PORTLAND, Maine — Spring has arrived, and many older adults in the U.S. who have been vaccinated are emerging from a hibernation imposed by the coronavirus pandemic.

They are relishing the little things like shopping and going to the gym, along with the big things like visiting relatives. Older adults who suffered the most during the pandemic are beginning to move forward with getting their lives on track.

Seventy-nine-year-old Florida resident Ken Hughes says there's an "extra level of confidence" among those who have been vaccinated. And many are able to see grandchildren. Bill Griffin of Maine got to hug his 3-year-old granddaughter for the first time in a year.

___

RIO DE JANEIRO — Brazil accounts for a quarter of the daily coronavirus global deaths, more than any other nation.

There is growing recognition among experts, mayors and governors that shutdowns are no longer avoidable. Restrictions on activity they implemented last year were half-hearted and consistently sabotaged by President Jair Bolsonaro.

The nation's seven-day average of 2,400 deaths stands to reach to 3,000 within weeks, experts told the Associated Press. Spikes of daily deaths could soon hit 4,000; on Friday there were 3,650 deaths.

Bolsonaro remains unconvinced of any need for clampdown, which leaves local leaders pursuing a patchwork of measures to prevent the death toll from spiraling. However, a more contagious variant is rampaging across Brazil. New daily cases topped 100,000 for the first time on Thursday.

Brazil's state-run science and technology institute, Fiocruz, on Tuesday called for a 14-day lockdown to reduce transmission. Delivery delays from AstraZeneca have slowed vaccines, with only 2% of the nation fully vaccinated.

There have been 12.4 million confirmed cases and more than 307,000 confirmed deaths in Brazil, second only to the United States.

___

ISLAMABAD — Pakistan officials say the country could face a worse situation than the first wave of the coronavirus if the current surge isn't controlled.

That's according to the Pakistan minister for planning and development Asada Umar. Pakistan has reported 4,668 new cases and 67 death in the last 24 hours, where eastern Punjab province and northern Pakistan are experiencing a third wave.

Umar says, "If the increase continues at this rate then in the next few days or next week, we will go beyond the level and peak we saw in the first wave in June."

Umar says disregard for precautionary measures has become a big reason for the sudden rapid increase in the spread of this disease. He warned of strict actions if people don't follow guidelines to counter the spread of the virus.

Pakistan has reported 649,824 total confirmed cases and 14,158 confirmed deaths.

___

LONDON — Britain's vaccines minister says booster shots designed to fight new variants of the coronavirus should be ready for distribution to people over 70 by September.

Nadhim Zahawi told the Daily Telegraph newspaper the government is expecting up to eight different shots to be available by the autumn, including some that may protect against variants.

He said booster shots would be given first to the frontline health workers, the elderly and people with serious health conditions that make them more vulnerable to COVID-19.

While much of Europe is seeing a new surge in the pandemic, Britain is counting on a rapid mass-vaccination program to help it end lockdown and curb Europe's coronavirus outbreak.

Nearly 30 million people in the U.K., accounting for 55% of all adults, have received a first dose of vaccine. The U.K. has recorded more than 126,000 confirmed deaths.

___

AUSTIN, Texas — A Texas judge is allowing the City of Austin to continue to require face coverings in local businesses weeks after Gov. Greg Abbott ended a statewide mask mandate and other COVID-19 safety measures.

The ruling Friday by state District Judge Lora Livingston is at least a temporary victory for local leaders in the liberal state capital who have repeatedly clashed with Abbott over his handling of the pandemic.

Face coverings have been loosely enforced in Texas, which earlier this month became the biggest state to drop COVID-19 restrictions. Texas Attorney General Ken Paxton is expected to appeal the ruling.

The roughly 3,400 patients hospitalized with COVID-19 in Texas is the lowest number since October. On Monday, Texas will begin making all adults eligible for coronavirus vaccinations.

___

GENEVA — A leader of the U.N.-backed program to ship coronavirus vaccines to needy people in low- and middle-income countries has expressed disappointment about supply delays from a key Indian manufacturer, but says he hopes the United States can begin sharing shots soon.

Dr. Seth Berkley is the CEO of Gavi, the Vaccine Alliance, and he says doses for health care workers and other high-risk groups in such countries to be delivered through the COVAX program will be set back weeks.

He was elaborating Friday on an announcement a day earlier from Gavi and partners that as many as 90 million doses of AstraZeneca vaccine made by the Serum Institute of India will be delayed through the end of April as India's government grapples with a spike in cases.

Berkley says that "we had hoped to reach all health care workers and high-risk groups by the end of March."

He says talks continue with India's government and SII "with the hope that we can get some of those doses freed up and be able to then move back into full swing scale-up later, in perhaps May."

___

PRAGUE — The Czech Republic's lower house of Parliament has voted to extend the state of emergency in one of the hardest hit European Union countries till April 11. The house's approval enables the government to keep in place a tight lockdown through Easter that ends on April 5.

Among the restrictions that became effective on March 1, people have been banned from traveling to other counties unless they go to work or have to take care of relatives. They are part of the measures that are believed to contribute to slowing down the spread of a highly contagious virus variant first found in Britain.

The day-to-day increase of new cases reached 7,853 on Thursday. It was the lowest number for a week day since Feb 8, and about 25% less than the same day a week ago.

According to the European Centre for Disease Prevention and Control, the 14-day case notification rate of new cases per 100,000 inhabitants was 1,328 in the Czech Republic, still the second highest in the EU after Estonia. The nation of 10.7 million had 1.5 million confirmed cases with 25,639 deaths.

___

JUNEAU, Alaska — The Alaska Department of Labor and Workforce Development reported that the state had 22,300 fewer jobs last month than it did in February 2020, citing an ongoing economic toll from the COVID-19 pandemic.

The department said the biggest losses were in the leisure and hospitality sector, which had 7,300 fewer jobs last month than in February 2020. Oil and gas had 3,900 fewer jobs, and the transportation, warehousing and utilities sector had 1,800 fewer jobs.

The report showed 2,000 fewer local government jobs last month compared to February 2020, with losses primarily tied to K-12 education. There were 200 more jobs in state government compared to February 2020, which the report says is largely due to pandemic-related hires for work such as contract tracing and processing unemployment insurance claims.

The department says job losses remain "historically large," with unemployment claims during the second week of last month nearly four times higher than the same week a year earlier.

___

PHOENIX — Health officials in Arizona announced an outdoor state-run COVID-19 mass vaccination site in the Phoenix suburb of Chandler will be replaced April 5 by a drive-thru operation inside a large business warehouse in Mesa in advance of approaching hot weather.

The Department of Health Services announced the vaccination site now run at Chandler-Gilbert Community College will use 30,000 square feet (2,787 square meters) of a 500,000-square-foot (46,451-square-meter) distribution center belonging to Dexcom Inc.

Republican Gov. Doug Ducey said the site switch will maintain the state's vaccination program's presence in southeastern Maricopa County while protecting staff, volunteers and people getting vaccinated.

The department said the 24-hour site at State Farm Stadium in Glendale will convert to overnight operations only and additional indoor sites are being sought in preparation for summer heat.

Department officials say people who received first doses at the Chandler-Gilbert facility on or after March 14 have been scheduled for their second doses at the Dexcom site, which will operate 7 a.m. to 5 p.m. seven days a week.

___

ATHENS, Greece — Authorities in Greece said students and teachers will have to use self-test kits for COVID-19 in order to attend classes when schools reopen.

Greece is planning to make the test kits freely available on a weekly basis to every resident of the country with a social security number, starting next month. The program is designed to allow for the reopening of schools as well as restaurants and retail businesses which have remained mostly closed since the lockdown was imposed in early November.

Vassilis Kontozamanis, the deputy health minister, said a legislative amendment in parliament would be needed to make testing mandatory for school attendance.

Greece is currently grappling with a surge in coronavirus infections which has seen many hospitals run by the state health system reach capacity. The country's center-right government says it plans to launch the tourism season in mid-May but has not yet given a date for schools and retail businesses to reopen. School children of all ages are currently attending compulsory online classes.

___

NICOSIA, Cyprus — Cyprus' Health Ministry says the spread of the U.K. variant of the coronavirus throughout the east Mediterranean island nation has marked an "alarming" increase, making up 95.5% of all new infections from Feb. 16 through Mar. 6.

The Ministry said statistics show that cases of the U.K. variant have more than doubled from the two-week period covering Feb. 1-Feb. 15.

It said various studies completed within several European countries have indicated that the U.K. variant is 50% more contagious. In Cyprus, it's also appearing in younger COVID-19 patients which has resulted in more hospitalizations of younger people.

Between Mar. 10-Mar. 23, 5,093 new COVID-19 cases have been diagnosed. The 14-day cumulative diagnosis rate is 573.5 per 100,000 population.

As of Mar. 23, a total of 42,028 COVID-19 cases have been diagnosed on the island nation of around 900,000 people, of which 248 died due to COVID-19.

___

The Link Lonk


March 27, 2021 at 07:06PM
https://ift.tt/3ddchN3

The Latest: Britain says variant booster ready by September - Minneapolis Star Tribune

https://ift.tt/2DVP6sH

Covid booster shots could go to at-risk groups in September – UK vaccines minister - The Guardian


People over-70 could begin getting booster shots to protect them against new coronavirus variants in September under plans for the future of the vaccine rollout.

The vaccines minister, Nadhim Zahawi, said the first booster doses would go to the top four priority groups, which also includes care home staff, NHS workers and the clinically extremely vulnerable.

He told the Telegraph (£) this was likely to begin in September and that the government was expecting up to eight different jabs to be available by the autumn, including one protecting against three different variants in a single dose.

A number will reportedly be manufactured in the UK, which could ease the pressure on supplies amid tensions with the European Union as it faces shortages from AstraZeneca.

Asked when the booster programme would begin, Zahawi told the newspaper: “The most likely date will be September.

“[Deputy chief medical officer] Jonathan Van-Tam thinks that if we are going to see a requirement for a booster jab to protect the most vulnerable, [it] would be around September.”

Ministers were facing pressure to protect the success of the vaccination programme against new variants from overseas, with discussions under way in Whitehall about expanding the travel “red list” of countries that mandate hotel quarantine on return.

Labour’s shadow home secretary, Nick Thomas-Symonds, said the government needed to do everything possible to stop new variants reaching the UK - and move to a comprehensive hotel quarantine system now. “The UK government are yet again doing too little, too late to secure our borders against Covid - and it’s the British people that will pay the price,” he said.

Elsewhere, the government was accused by a senior Tory of failing black, Asian and minority ethnic (BAME) communities and young women on hesitancy towards vaccines.

Caroline Nokes, the chairwoman of the women and equalities committee, said in a letter to Zahawi that not tackling the issue could be “devastating” for vaccine-hesitant groups as well as wider society.

The Link Lonk


March 27, 2021 at 03:40PM
https://ift.tt/39BocUf

Covid booster shots could go to at-risk groups in September – UK vaccines minister - The Guardian

https://ift.tt/2DVP6sH

Veterans, families may need to get COVID vaccine boosters later this year - Military Times


Veterans Affairs officials still have millions of coronavirus vaccine doses they hope to deliver in coming months, but they’re already looking ahead to the possibility of booster shots for vaccinated veterans this fall.

That’s because VA medical experts — along with other health professionals worldwide — are planning for the next potential wave of pandemic problems, as COVID-19 variants emerge and researchers develop a better understanding of how effective current vaccines can be against them.

“Right now, it appears that we’ll be able to publish in the next few weeks the evidence that between seven and nine months we can feel comfortable that [vaccinated] individuals are still protected,” acting VA Under Secretary for Health Richard Stone told reporters at a department press conference Friday.

“The next question you ask is if this is an endemic disease — which hundreds of researchers and public health leaders believe, and I am one of those — how do we reduce mortality and hospitalization because of it? Clearly, it’s going to be the ability to deliver more immunizations.”

U.S. Army veteran Gene Moy, 103, of Seattle, receives the second shot of the Pfizer COVID-19 vaccination on Feb. 23, 2021, from a nurse at the VA Puget Sound Health Care System campus in Seattle. (Ted S. Warren/AP)

Department medical staff have been working alongside officials from the Centers for Disease Control and Prevention in recent months on coronavirus antibody research.

Based on those findings so far, Stone said, VA officials have begun taking steps to treat the current pandemic as an annual problem, similar to influenza, with “recurrent immunizations” for veterans and their families.

That work is taking place as VA officials are working to rapidly increase the pace of vaccinations in their existing medical system, in response to new legislation from Congress dramatically expanding the population eligible to receive shots at VA medical centers.

Until earlier this week, only veterans who qualified for VA health care — less than half of the estimated 19 million veterans in America today — were eligible to receive vaccine doses through VA, along with a small number of caregivers.

Now, under the new rules, all veterans, their spouses and caregivers are eligible. VA’s potential pool of individuals to vaccinate jumped from about 7 million to more than 30 million with the change.

VA Secretary Denis McDonough said the department has set a goal of May 1 for all of those individuals to be able to sign up for vaccine waiting lists.

“I take great pride in the fact that Congress and the President voted their confidence in VA’s capacity here,” he told reporters. “And that’s by virtue of how the team has run the vaccination program to date.”

Department officials have administered more than 3.3 million vaccine doses since mid-December, and fully vaccinated more than 1.6 million veterans and about 33,000 non-VA federal employees through arrangements with other agencies.

Stone said he expects the department’s weekly allotment of vaccines to rise from about 200,000 to 250,000 over the next month, and believes VA staff could deliver as much at 300,000 each week if supplies allow.

Those supplies will be the determining factor on when most veterans can actually visit VA to receive vaccinations. Stone said that department leaders have approved pilot programs in areas where local authorities believe they have vaccinated most of the previously eligible population, to start widening the number of veterans helped.

“So areas up in the northeast and down in the mid- and southwest have volunteered to be pilots,” he said. “We also began working yesterday with officials down in Florida on expansion.”

A preservation technician works to restore military personnel records damaged during a July 12, 1973, fire at the National Personnel Records Center. (National Archives via National Guard)

McDonough said part of the challenge is finding ways to quickly enter potentially millions more individuals into VA’s medical records system, to ensure vaccines and medical issues are being tracked.

For federal partners receiving doses, the process has taken up to 15 minutes of paperwork and data entry per individual. McDonough said he hopes to streamline that in coming weeks.

VA officials are encouraging veterans interested in the vaccine to contact local officials and ask about eligibility timelines.

Department leaders also have planned for April more than 30 missions by mobile-health unit teams to rural areas across the country, in an effort to ensure veterans in hard-to-reach locations are helped. That’s on top of more than 300 missions already run since December, which have vaccinated more than 86,000 people.

At least 240,000 VA patients have tested positive for coronavirus in the last year, with more than 11,200 dying from complications related to the illness. Nationwide, nearly 30 million individuals have contracted coronavirus, and nearly 544,000 have died.

The Link Lonk


March 27, 2021 at 03:01AM
https://ift.tt/3u3zvwb

Veterans, families may need to get COVID vaccine boosters later this year - Military Times

https://ift.tt/2DVP6sH

Featured Post

Booster may be needed for J&J shot as Delta variant spreads; some experts already taking them - ABC27

Coronavirus by: Reuters , via Nexstar Media Wire Posted: Jun 29, 2021 / 02:02 PM EDT / Updated: Jun 29, 2021 / 02:02 PM EDT THORN...

Popular Posts